Genconn introduces cutting edge testing/screening equipment from Europe and the US. We also work with renowned biotechnology manufacturers in the expansion of clinical genomic testing in the Taiwan market to provide clinical testing or medical research. This enables detection on genomic variation of a particular cancer and optimize drug therapy. Maximum efficiency with minimal adverse effects on individual patient’s drug adaptation & resistance when each patient’s genotype is identified. Subsequent steps are followed for tumor variation, drug responses and tumor recurrences.
Genconn collaborates with both national and international medical centers/ pharmaceutical companies to conduct clinical studies that aim at prolonging patients survival in the current treatment regime and facilitate prospect cancer research projects.